Capricor Therapeutics CAPR Enterprise value

Enterprise value at other companies

PfizerPFE

$222.4B+9.2%

Sarepta Therapeutics, Inc.SRPT

$1.52B-2.9%

PTC TherapeuticsPTCT

$5.2B+77.3%

Celldex TherapeuticsCLDX

$2.88B+103%

Dyne Therapeutics, Inc.DYN

$2.41B+228%

CytokineticsCYTK

$11.71B+178%

FAQ

What is Capricor Therapeutics's enterprise value?

Capricor Therapeutics (CAPR) reported enterprise value of $1.66B in Q1 2026.

How has Capricor Therapeutics's enterprise value changed year-over-year?

Capricor Therapeutics's enterprise value increased by 308.4% year-over-year, from $405.92M to $1.66B.

What is the long-term trend for Capricor Therapeutics's enterprise value?

Over 5 years (2020 to 2025), Capricor Therapeutics's enterprise value has grown at a 91.6% compound annual growth rate (CAGR), from $50.24M to $1.3B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.